IMWG Series

The International Myeloma Working Group (IMWG) Conference Series: Making Sense of Treatment is a medical education program created by the International Myeloma Foundation (IMF) to bring lively expert discussion of important myeloma treatment issues into the homes and offices of viewers around the world via live webcast.

Dec
05
IMWG: Role of autotransplant
Exploring the role of transplants in myeloma treatment
Jun
15
IMWG Conference Series - Copenhagen 2016: How do you sequence new therapies?
Even though there is a tremendous access to new drug therapies, doctors have yet to determine the best way to use these new therapies. The doctors conclude that some of the most exciting therapies(...)
Jun
15
IMWG Conference Series - Copenhagen 2016: Is maintenance a standard of care?
Discussed is the value of Revlimid (lenalidomide) maintenance post-autologous stem cell transplant (as based on a recent French study). IMWG Myeloma Experts debate the latest trends in treatment June(...)
Jun
15
IMWG Conference Series - Copenhagen 2016: How do you use MRD testing?
Discussed are the new IMWG Criteria in MRD testing in multiple myeloma, which is to be published in Lancet Oncology. Attention is given as to how to use the testing going forward with patient care.(...)
Jun
15
IMWG Conference Series - Copenhagen 2016: Are you proactive regarding your patients’ comorbidities?
The third question of the series is “Are you proactive regarding your patients’ possible comorbidities?” In particular, the doctors consider patient characteristics such as age, performance status,(...)
Jun
15
IMWG Conference Series - Copenhagen 2016: How does risk status affect treatment?”
The doctors consider mSMART classification to look at high-, intermediate-, and standard-risk myeloma. They discuss, with the increasing depth of response in myeloma with the newer drugs, how doctors(...)